TG Therapeutics News

TG Therapeutics Analyst Ratings

BenzingaMay 2 09:03 ET

Sell Rating on TG Therapeutics: Caution Amid Competitive Threats and Decelerating Prescription Growth

TipRanksMay 2 05:25 ET

Hold Rating on TG Therapeutics Amidst Strong Briumvi Launch and Competitive Market Pressures

TipRanksMay 1 17:35 ET

Briumvi's Market Share Growth and TG Therapeutics' Strong Financial Outlook Justify Buy Rating

TipRanksApr 30 12:45 ET

Bank of America Securities Keeps Their Sell Rating on TG Therapeutics (TGTX)

TipRanksApr 23 09:38 ET

TG Therapeutics Analyst Ratings

BenzingaApr 18 13:25 ET

Analysts Are Bullish on These Healthcare Stocks: Eli Lilly & Co (LLY), TG Therapeutics (TGTX)

TipRanksApr 18 09:30 ET

TG Therapeutics Analyst Ratings

BenzingaMar 1 14:20 ET

Analysts Offer Insights on Healthcare Companies: Alignment Healthcare (ALHC), TG Therapeutics (TGTX) and Amicus (FOLD)

TipRanksFeb 29 05:40 ET

Goldman Sachs Sticks to Their Hold Rating for TG Therapeutics (TGTX)

TipRanksFeb 28 12:05 ET

TG Therapeutics: Promising European Expansion and Strong Financial Outlook Justify Buy Rating

TipRanksFeb 26 11:45 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: TG Therapeutics (TGTX), Zoetis (ZTS) and Teladoc (TDOC)

TipRanksFeb 13 09:02 ET

TG Therapeutics Analyst Ratings

BenzingaFeb 5 15:07 ET

Buy Rating Affirmed for TG Therapeutics on Strong Briumvi Sales and Favorable Market Dynamics

TipRanksFeb 2 12:45 ET

TG Therapeutics Analyst Ratings

BenzingaJan 11 07:50 ET

Goldman Sachs Sticks to Their Hold Rating for TG Therapeutics (TGTX)

TipRanksJan 9 22:55 ET

Robust Financial Performance and Promising Sales Trajectory Drive Edward White's Buy Rating for TG Therapeutics

TipRanksNov 2, 2023 14:57 ET

Analysts Offer Insights on Healthcare Companies: TG Therapeutics (TGTX), Aurinia Pharmaceuticals (AUPH) and Cerevel Therapeutics Holdings (CERE)

TipRanksNov 2, 2023 14:00 ET

JP Morgan Maintains Overweight on TG Therapeutics, Raises Price Target to $23

BenzingaNov 1, 2023 15:48 ET

TG Therapeutics Analyst Ratings

BenzingaNov 1, 2023 15:46 ET